Showing results 2 to 5 of 5
HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway Jung, Kyung Hee; Choi, Myung-Joo; Hong, Seunghee; Lee, Hyunseung; Hong, Sang-Won; Zheng, Hong-Mei; Lee, Hee-Seung; et al, CANCER LETTERS, v.316, no.2, pp.187 - 195, 2012-03 |
IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma Lee, Ju-Hee; Lee, Hyunseung; Yun, Sun-Mi; Jung, Kyung Hee; Jeong, Yujeong; Yan, Hong Hua; Hong, Sungwoo; et al, CANCER LETTERS, v.329, no.1, pp.99 - 108, 2013-02 |
Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor Jung, Kyung Hee; Zheng, Hong-Mei; Jeong, Yujeong; Choi, Myung-Joo; Lee, Hyunseung; Hong, Sang-Won; Lee, Hee-Seung; et al, CANCER LETTERS, v.328, no.1, pp.176 - 187, 2013-01 |
The effect of HS-111, a novel thiazolamine derivative, on apoptosis and angiogenesis of hepatocellular carcinoma cells Choi, Myung-Joo; Lee, Hyunseung; Lee, Ju-Hee; Jung, Kyung Hee; Kim, Donghee; Hong, Sungwoo; Hong, Soon-Sun, ARCHIVES OF PHARMACAL RESEARCH, v.35, no.4, pp.747 - 754, 2012-03 |
Discover